Functional outcomes and quality of life after a 6-month early intervention program for oral cancer survivors: a single-arm clinical trial
- PMID: 29492348
- PMCID: PMC5827017
- DOI: 10.7717/peerj.4419
Functional outcomes and quality of life after a 6-month early intervention program for oral cancer survivors: a single-arm clinical trial
Abstract
Background: Advanced treatment of oral cancer increases survival rates; however, it also increases the risk of developing shoulder dysfunction, dysphagia, oral dysfunction, donor site morbidity and psychological issues. This single-arm preliminary pilot study aims to explore the effects of a six-month early intervention program following reconstructive surgery in oral cancer survivors.
Methods: A total of 65 participants were analyzed following reconstructive surgery. Outcome measurements were taken during the first visit, and at one, three and six months after reconstructive surgery.
Results: Scapular muscle strength and shoulder range of motion progressively improved during the 6-month follow-up. The mean Disability of the Arms, Shoulder and Hand (DASH) score showed significant improvement at 1 month (p < .001). Health related QoL showed significant differences between baseline and 6-months post-surgery scores on global health and on most of the function and symptom scales. The predicted return-to-work rate was 80% at one year after the operation. Return-to-work rate differs in different vocational types, with a higher rate of return in the skilled or semi-skilled (87.5%) and self-employed (86.7%).
Conclusions: We suggest that early integrated intervention program with a follow-up of at least six months following reconstructive surgery may help develop and identify intervention guidelines and goals in the initial six months of treatment following neck dissection in oral cancer survivors.
Keywords: Oral cancer; Quality of life; Return to work; Shoulder dysfunction.
Conflict of interest statement
The authors declare there are no competing interests.
Figures




References
-
- Beaton DE, Bombardier C, Katz JN, Wright JG, Wells G, Boers M, Strand V, Shea B. Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference. Journal of Rheumatology. 2001;28:400–405. - PubMed
-
- Bjordal K, De Graeff A, Fayers PM, Hammerlid E, Van Pottelsberghe C, Curran D, Ahlner-Elmqvist M, Maher EJ, Meyza JW, Bredart A, Soderholm AL, Arraras JJ, Feine JS, Abendstein H, Morton RP, Pignon T, Huguenin P, Bottomly A, Kaasa S. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. European Journal of Cancer. 2000;36:1796–1807. doi: 10.1016/S0959-8049(00)00186-6. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases